Precision Biosciences DTIL
NASDAQ DTIL
$6.33 +0.07 (+1.12%)
At close: Oct 1, 2026 · 4:00 PM EDT

Precision Biosciences (DTIL) Total Current Liabilities (2018 - 2026)

Updated

Precision Biosciences (DTIL) reported Total Current Liabilities of $7.14 million for fiscal Q2 2026 (quarter ended Jun 30, 2026), down 47.4% from $13.57 million a year earlier and down 7.9% from the prior quarter.

Analysis

Precision Biosciences (DTIL) Total Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025 (ended Dec 31, 2025), Precision Biosciences posted Total Current Liabilities of $8.91 million, down 40.5% from FY2024.

  • Total Current Liabilities has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -26.9% (FY2020 to FY2025).
  • By fiscal year, Total Current Liabilities came in at $14.98 million in FY2024 (-70.0%), $49.99 million in FY2023 (-16.2%), $59.66 million in FY2022 (+65.8%) and $35.98 million in FY2021 (-16.0%).
  • The fiscal Q2 2026 figure ranks as the lowest quarterly Total Current Liabilities in data going back to fiscal Q4 2018.
  • Year over year, Total Current Liabilities has now declined in each of the last three quarters, with an average decline of 46.0% over the last eight quarters.
  • The high point for year-over-year Total Current Liabilities in five years was fiscal Q3 2022 (growth of 67.6%); the low point was fiscal Q3 2024 (a decline of 76.3%).
  • Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $7.76 million (Q1 2026), $8.91 million (Q4 2025) and $15 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 54.90 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 41.64 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -31.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.02 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.94 Bn
10 Precision Biosciences 165.47 Mn -183.71 Mn - 7.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.14 Mn
Mar 31, 2026 7.76 Mn
Dec 31, 2025 8.91 Mn
Sep 30, 2025 15.00 Mn
Jun 30, 2025 13.57 Mn
Mar 31, 2025 12.39 Mn
Dec 31, 2024 14.98 Mn
Sep 30, 2024 11.98 Mn
Jun 30, 2024 32.96 Mn
Mar 31, 2024 33.34 Mn
Dec 31, 2023 49.99 Mn
Sep 30, 2023 50.62 Mn
Jun 30, 2023 56.40 Mn
Mar 31, 2023 46.86 Mn
Dec 31, 2022 59.66 Mn
Sep 30, 2022 61.15 Mn
Jun 30, 2022 53.92 Mn
Mar 31, 2022 29.11 Mn
Dec 31, 2021 35.98 Mn
Sep 30, 2021 36.48 Mn
API Access

Precision Biosciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=DTIL&period=max&api_key=YOUR_API_KEY